Access cutting-edge paroxysmal nocturnal hemoglobinuria (pnh) treatment through this phase 2 clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Atlanta location
Preparing your pre-screening questions…
Access paroxysmal nocturnal hemoglobinuria (pnh) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related paroxysmal nocturnal hemoglobinuria (pnh) treatment provided free
Check if you qualify for this paroxysmal nocturnal hemoglobinuria (pnh) clinical trial in Atlanta, GA
No-Cost Study Care
Local to Atlanta
Convenient for GA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this study is to evaluate the safety, effectiveness, and biological activity (how the investigational medication is processed by the body) of pegcetacoplan in 12-17 year-olds (adolescents) who have paroxysmal nocturnal hemoglobinuria (PNH).
Sponsor: Apellis Pharmaceuticals, Inc.
Yes, this clinical trial (NCT04901936) has an active research site in Atlanta, GA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for paroxysmal nocturnal hemoglobinuria (pnh) treatment options in Atlanta, GA, this clinical trial (NCT04901936) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced paroxysmal nocturnal hemoglobinuria (pnh) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all paroxysmal nocturnal hemoglobinuria (pnh) clinical trials near you to find additional studies recruiting in your area.
See all prurigo nodularis clinical trials recruiting in Atlanta — not just this study.
Browse Prurigo Nodularis Trials in Atlanta →